282 related articles for article (PubMed ID: 31262158)
1. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
[TBL] [Abstract][Full Text] [Related]
2. Influence of metformin, sodium dichloroacetate and their combination on the hematological and biochemical blood parameters of rats with gliomas C6.
Prokhorova IV; Pyaskovskaya ON; Kolesnik DL; Solyanik GI
Exp Oncol; 2018 Oct; 40(3):205-210. PubMed ID: 30284997
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma.
Kolesnik DL; Pyaskovskaya ON; Yakshibaeva YR; Solyanik GI
Exp Oncol; 2019 Mar; 41(1):14-19. PubMed ID: 30932416
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia enhances antitumor activity of dichloroacetate.
Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment changes tumor cell sensitivity to action of energy metabolism modifiers.
Pyaskovskaya ON; Kolesnik DL; Prokhorova IV; Burlaka АP; Gorbach OI; Solyanik GI
Exp Oncol; 2020 Sep; 42(3):192-196. PubMed ID: 32996739
[TBL] [Abstract][Full Text] [Related]
8. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activity of metformin in vitro does not correlate with its antitumor action in vivo.
Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Gorbik GV; Solyanik GI
Exp Oncol; 2017 Dec; 39(4):264-268. PubMed ID: 29284782
[TBL] [Abstract][Full Text] [Related]
10. Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1.
Voltan R; Rimondi E; Melloni E; Gilli P; Bertolasi V; Casciano F; Rigolin GM; Zauli G; Secchiero P
Oncotarget; 2016 Apr; 7(14):18965-77. PubMed ID: 26959881
[TBL] [Abstract][Full Text] [Related]
11. Aconitine-containing agent enhances antitumor activity of dichloroacetate against Ehrlich carcinoma.
Pyaskovskaya ON; Boychuk IV; Fedorchuk AG; Kolesnik DL; Dasyukevich OI; Solyanik GI
Exp Oncol; 2015 Sep; 37(3):192-6. PubMed ID: 26422103
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
Choi YW; Lim IK
Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
[TBL] [Abstract][Full Text] [Related]
13. Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
Albayrak G; Konac E; Dere UA; Emmez H
Turk Neurosurg; 2021; 31(2):233-237. PubMed ID: 33372258
[TBL] [Abstract][Full Text] [Related]
14. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
[TBL] [Abstract][Full Text] [Related]
15. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
[TBL] [Abstract][Full Text] [Related]
16. Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells.
Florio R; De Lellis L; Veschi S; Verginelli F; di Giacomo V; Gallorini M; Perconti S; Sanna M; Mariani-Costantini R; Natale A; Arduini A; Amoroso R; Cataldi A; Cama A
Sci Rep; 2018 Sep; 8(1):13610. PubMed ID: 30206358
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation.
Duan Y; Zhao X; Ren W; Wang X; Yu KF; Li D; Zhang X; Zhang Q
Onco Targets Ther; 2013; 6():189-98. PubMed ID: 23515860
[TBL] [Abstract][Full Text] [Related]
18. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
19. Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.
Isakovic A; Harhaji L; Stevanovic D; Markovic Z; Sumarac-Dumanovic M; Starcevic V; Micic D; Trajkovic V
Cell Mol Life Sci; 2007 May; 64(10):1290-302. PubMed ID: 17447005
[TBL] [Abstract][Full Text] [Related]
20. Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.
Ward NP; Poff AM; Koutnik AP; D'Agostino DP
PLoS One; 2017; 12(6):e0180061. PubMed ID: 28644886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
